advertisement
Yu M 21
Showing records 1 to 21 | Display all abstracts from Yu M112198 Efficacy and safety of primary customized phacoemulsification combined with goniosynechialysis for refractory acute primary angle closure
Wu X
International Ophthalmology 2023; 43: 4515-4525
112871 Six-Year Incidence and Risk Factors for Primary Open-Angle Glaucoma and Ocular Hypertension: The Singapore Epidemiology of Eye Diseases Study
Thakur S
Ophthalmology. Glaucoma 2024; 7: 157-167
112369 Inhibition of TGF-β2-Induced Trabecular Meshwork Fibrosis by Pirfenidone
Zhu X
Translational vision science & technology 2023; 12: 21
112198 Efficacy and safety of primary customized phacoemulsification combined with goniosynechialysis for refractory acute primary angle closure
Liu X
International Ophthalmology 2023; 43: 4515-4525
112369 Inhibition of TGF-β2-Induced Trabecular Meshwork Fibrosis by Pirfenidone
Zeng B
Translational vision science & technology 2023; 12: 21
112871 Six-Year Incidence and Risk Factors for Primary Open-Angle Glaucoma and Ocular Hypertension: The Singapore Epidemiology of Eye Diseases Study
Lavanya R
Ophthalmology. Glaucoma 2024; 7: 157-167
112198 Efficacy and safety of primary customized phacoemulsification combined with goniosynechialysis for refractory acute primary angle closure
Xiao S
International Ophthalmology 2023; 43: 4515-4525
112871 Six-Year Incidence and Risk Factors for Primary Open-Angle Glaucoma and Ocular Hypertension: The Singapore Epidemiology of Eye Diseases Study
Yu M
Ophthalmology. Glaucoma 2024; 7: 157-167
112369 Inhibition of TGF-β2-Induced Trabecular Meshwork Fibrosis by Pirfenidone
Wu C
Translational vision science & technology 2023; 12: 21
112871 Six-Year Incidence and Risk Factors for Primary Open-Angle Glaucoma and Ocular Hypertension: The Singapore Epidemiology of Eye Diseases Study
Tham YC
Ophthalmology. Glaucoma 2024; 7: 157-167
112369 Inhibition of TGF-β2-Induced Trabecular Meshwork Fibrosis by Pirfenidone
Chen Z
Translational vision science & technology 2023; 12: 21
112198 Efficacy and safety of primary customized phacoemulsification combined with goniosynechialysis for refractory acute primary angle closure
Cai Y
International Ophthalmology 2023; 43: 4515-4525
112369 Inhibition of TGF-β2-Induced Trabecular Meshwork Fibrosis by Pirfenidone
Yu M
Translational vision science & technology 2023; 12: 21
112198 Efficacy and safety of primary customized phacoemulsification combined with goniosynechialysis for refractory acute primary angle closure
Yu M
International Ophthalmology 2023; 43: 4515-4525
112871 Six-Year Incidence and Risk Factors for Primary Open-Angle Glaucoma and Ocular Hypertension: The Singapore Epidemiology of Eye Diseases Study
Da Soh Z
Ophthalmology. Glaucoma 2024; 7: 157-167
112369 Inhibition of TGF-β2-Induced Trabecular Meshwork Fibrosis by Pirfenidone
Yang Y
Translational vision science & technology 2023; 12: 21
112871 Six-Year Incidence and Risk Factors for Primary Open-Angle Glaucoma and Ocular Hypertension: The Singapore Epidemiology of Eye Diseases Study
Teo ZL
Ophthalmology. Glaucoma 2024; 7: 157-167
112198 Efficacy and safety of primary customized phacoemulsification combined with goniosynechialysis for refractory acute primary angle closure
Xu B
International Ophthalmology 2023; 43: 4515-4525
112871 Six-Year Incidence and Risk Factors for Primary Open-Angle Glaucoma and Ocular Hypertension: The Singapore Epidemiology of Eye Diseases Study
Koh V
Ophthalmology. Glaucoma 2024; 7: 157-167
112198 Efficacy and safety of primary customized phacoemulsification combined with goniosynechialysis for refractory acute primary angle closure
Wang Y; Wu W
International Ophthalmology 2023; 43: 4515-4525
112871 Six-Year Incidence and Risk Factors for Primary Open-Angle Glaucoma and Ocular Hypertension: The Singapore Epidemiology of Eye Diseases Study
Majithia S; Qian C; Aung T; Nongpiur ME; Cheng CY
Ophthalmology. Glaucoma 2024; 7: 157-167
